{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:00:09Z","timestamp":1772028009471,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12149-025-02148-y","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T06:53:36Z","timestamp":1766991216000},"page":"231-247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic accuracy of \u00b9\u2078F-FDG PET\/CT radiomics for non-invasive prediction of PD-L1 expression in non-small cell lung cancer: A systematic review and meta-analysis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7225-567X","authenticated-orcid":false,"given":"Mohsen","family":"Salimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6252-8101","authenticated-orcid":false,"given":"Pouria","family":"Vadipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6813-4847","authenticated-orcid":false,"given":"Adnan","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7220-6719","authenticated-orcid":false,"given":"Maryam","family":"Mabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parsa","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-0534","authenticated-orcid":false,"given":"Sharareh","family":"Seifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"2148_CR1","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1097\/CM9.0000000000002529","volume":"136","author":"C Li","year":"2023","unstructured":"Li C, Lei S, Ding L, Xu Y, Wu X, Wang H, et al. Global burden and trends of lung cancer incidence and mortality. Chin Med J. 2023;136:1583\u201390. https:\/\/doi.org\/10.1097\/CM9.0000000000002529.","journal-title":"Chin Med J"},{"key":"2148_CR2","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1016\/S1470-2045(14)71180-5","volume":"16","author":"MG Oser","year":"2015","unstructured":"Oser MG, Niederst MJ, Sequist LV, Engelman JA. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol. 2015;16:e165\u201372. https:\/\/doi.org\/10.1016\/S1470-2045(14)71180-5.","journal-title":"Lancet Oncol"},{"key":"2148_CR3","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.jtho.2024.06.010","volume":"19","author":"JD Spicer","year":"2024","unstructured":"Spicer JD, Cascone T, Wynes MW, Ahn M-J, Dacic S, Felip E, et al. Neoadjuvant and adjuvant treatments for early stage resectable NSCLC: consensus recommendations from the International Association for the Study of Lung Cancer. J Thorac Oncol. 2024;19:1373\u2013414. https:\/\/doi.org\/10.1016\/j.jtho.2024.06.010.","journal-title":"J Thorac Oncol"},{"key":"2148_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00764-2016","volume":"49","author":"F McDonald","year":"2017","unstructured":"McDonald F, De Waele M, Hendriks LEL, Faivre-Finn C, Dingemans A-MC, Van Schil PE. Management of stage I and II nonsmall cell lung cancer. Eur Respir J. 2017;49:1600764. https:\/\/doi.org\/10.1183\/13993003.00764-2016.","journal-title":"Eur Respir J"},{"key":"2148_CR5","doi-asserted-by":"publisher","first-page":"823618","DOI":"10.3389\/fimmu.2022.823618","volume":"13","author":"H Mamdani","year":"2022","unstructured":"Mamdani H, Matosevic S, Khalid AB, Durm G, Jalal SI. Immunotherapy in lung cancer: current landscape and future directions. Front Immunol. 2022;13:823618. https:\/\/doi.org\/10.3389\/fimmu.2022.823618.","journal-title":"Front Immunol"},{"key":"2148_CR6","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.chest.2018.08.1048","volume":"154","author":"K Suresh","year":"2018","unstructured":"Suresh K, Naidoo J, Lin CT, Danoff S. Immune checkpoint immunotherapy for non-small cell lung cancer. Chest. 2018;154:1416\u201323. https:\/\/doi.org\/10.1016\/j.chest.2018.08.1048.","journal-title":"Chest"},{"key":"2148_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","volume":"15","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Chen M, Nie H, Yuan Y. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Hum Vaccin Immunother. 2019;15:1111\u201322. https:\/\/doi.org\/10.1080\/21645515.2019.1571892.","journal-title":"Hum Vaccin Immunother"},{"key":"2148_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/LCTT.S113177","volume":"8","author":"N Seetharamu","year":"2017","unstructured":"Seetharamu N, Preeshagul I, Sullivan K. New PD-L1 inhibitors in non-small cell lung cancer \u2013 impact of Atezolizumab. LCTT. 2017;8:67\u201378. https:\/\/doi.org\/10.2147\/LCTT.S113177.","journal-title":"LCTT"},{"key":"2148_CR9","doi-asserted-by":"publisher","first-page":"964442","DOI":"10.3389\/fimmu.2022.964442","volume":"13","author":"Q Tang","year":"2022","unstructured":"Tang Q, Chen Y, Li X, Long S, Shi Y, Yu Y, et al. The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front Immunol. 2022;13:964442. https:\/\/doi.org\/10.3389\/fimmu.2022.964442.","journal-title":"Front Immunol"},{"key":"2148_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6717912","volume":"2020","author":"X-J Chen","year":"2020","unstructured":"Chen X-J, Yuan S-Q, Duan J-L, Chen Y-M, Chen S, Wang Y, et al. The value of PD-L1 expression in predicting the efficacy of anti-PD-1 or anti-PD-L1 therapy in patients with cancer: a systematic review and meta-analysis. Dis Markers. 2020;2020:1\u201314. https:\/\/doi.org\/10.1155\/2020\/6717912.","journal-title":"Dis Markers"},{"key":"2148_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.lungcan.2022.03.002","volume":"166","author":"R Butter","year":"2022","unstructured":"Butter R, Hondelink LM, Van Elswijk L, Blaauwgeers JLG, Bloemena E, Britstra R, et al. The impact of a pathologist\u2019s personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer. Lung Cancer. 2022;166:143\u20139. https:\/\/doi.org\/10.1016\/j.lungcan.2022.03.002.","journal-title":"Lung Cancer"},{"key":"2148_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.lungcan.2019.06.005","volume":"134","author":"A Haragan","year":"2019","unstructured":"Haragan A, Field JK, Davies MPA, Escriu C, Gruver A, Gosney JR. Heterogeneity of PD-L1 expression in non-small cell lung cancer: implications for specimen sampling in predicting treatment response. Lung Cancer. 2019;134:79\u201384. https:\/\/doi.org\/10.1016\/j.lungcan.2019.06.005.","journal-title":"Lung Cancer"},{"key":"2148_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtocrr.2023.100532","volume":"4","author":"EB Ulas","year":"2023","unstructured":"Ulas EB, Hashemi SMS, Houda I, Kaynak A, Veltman JD, Fransen MF, et al. Predictive value of combined positive score and tumor proportion score for immunotherapy response in advanced NSCLC. JTO Clinical and Research Reports. 2023;4:100532. https:\/\/doi.org\/10.1016\/j.jtocrr.2023.100532.","journal-title":"JTO Clinical and Research Reports"},{"key":"2148_CR14","unstructured":"Yousefi-Koma AY-K, Panah-Moghaddam M, Kalff V. The utility of metabolic imaging by 18F-FDG PET\/CT in lung cancer: impact on diagnosis and staging. TANAFFOS (Respiration; 1999. p. 12."},{"key":"2148_CR15","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/bioengineering10121435","volume":"10","author":"L Pinto-Coelho","year":"2023","unstructured":"Pinto-Coelho L. How artificial intelligence is shaping medical imaging technology: a survey of innovations and applications. Bioengineering. 2023;10:1435. https:\/\/doi.org\/10.3390\/bioengineering10121435.","journal-title":"Bioengineering"},{"key":"2148_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40779-023-00458-8","volume":"10","author":"Y-P Zhang","year":"2023","unstructured":"Zhang Y-P, Zhang X-Y, Cheng Y-T, Li B, Teng X-Z, Zhang J, et al. Artificial intelligence-driven radiomics study in cancer: the role of feature engineering and modeling. Mil Med Res. 2023;10:22. https:\/\/doi.org\/10.1186\/s40779-023-00458-8.","journal-title":"Mil Med Res"},{"key":"2148_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07453-2","author":"FJ Kiss","year":"2025","unstructured":"Kiss FJ, J\u00e1r\u00f3 AI, M\u00e1th\u00e9 D, Benedek C, Madaras V, Manno-Kov\u00e1cs A, et al. Predicting PD-L1 expression status in NSCLC using radiomic analysis of 18 F-FDG-PET\/CT images. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07453-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2148_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2025.106915","volume":"86","author":"M Peng","year":"2025","unstructured":"Peng M, Wang M, Yang X, Wang Y, Xie L, An W, et al. Prediction of PD-L1 expression in NSCLC patients using PET\/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients. Clin Radiol. 2025;86:106915. https:\/\/doi.org\/10.1016\/j.crad.2025.106915.","journal-title":"Clin Radiol"},{"key":"2148_CR19","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"2148_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009.","journal-title":"Ann Intern Med"},{"key":"2148_CR21","doi-asserted-by":"publisher","unstructured":"Kocak B, Tugba Akinci D\u2019Antonoli, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I et al. METhodological radiomics score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII. Insights into Imaging 2024;15. https:\/\/doi.org\/10.1186\/s13244-023-01572-w","DOI":"10.1186\/s13244-023-01572-w"},{"key":"2148_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"key":"2148_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","volume":"58","author":"JJ Deeks","year":"2005","unstructured":"Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882\u201393. https:\/\/doi.org\/10.1016\/j.jclinepi.2005.01.016.","journal-title":"J Clin Epidemiol"},{"key":"2148_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111825","volume":"183","author":"AT St\u00fcber","year":"2025","unstructured":"St\u00fcber AT, Heimer MM, Ta J, Fabritius MP, Hoppe BF, Sheikh G, et al. Replication study of PD-L1 status prediction in NSCLC using PET\/CT radiomics. Eur J Radiol. 2025;183:111825. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111825.","journal-title":"Eur J Radiol"},{"key":"2148_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/diagnostics15050543","volume":"15","author":"H Zhang","year":"2025","unstructured":"Zhang H, Meng X, Wang Z, Zhou X, Liu Y, Li N. Predicting PD-L1 in lung adenocarcinoma using 18F-FDG PET\/CT radiomic features. Diagnostics. 2025;15:543. https:\/\/doi.org\/10.3390\/diagnostics15050543.","journal-title":"Diagnostics"},{"key":"2148_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2024.100549","volume":"12","author":"B Li","year":"2024","unstructured":"Li B, Su J, Liu K, Hu C. Deep learning radiomics model based on PET\/CT predicts PD-L1 expression in non-small cell lung cancer. Eur J Radiol Open. 2024;12:100549. https:\/\/doi.org\/10.1016\/j.ejro.2024.100549.","journal-title":"Eur J Radiol Open"},{"key":"2148_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-023-00956-9","volume":"13","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhao Y, Zhang J, Zhang Z, Liu L, Zhao X. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [18F]FDG PET\/CT radiomics. EJNMMI Res. 2023;13:4. https:\/\/doi.org\/10.1186\/s13550-023-00956-9.","journal-title":"EJNMMI Res"},{"key":"2148_CR28","doi-asserted-by":"publisher","first-page":"e732","DOI":"10.1016\/j.crad.2023.06.003","volume":"78","author":"YB Wang","year":"2023","unstructured":"Wang YB, He X, Song X, Li M, Zhu D, Zhang F, et al. The radiomic biomarker in non-small cell lung cancer: 18F-FDG PET\/CT characterisation of programmed death-ligand 1 status. Clin Radiol. 2023;78:e732\u201340. https:\/\/doi.org\/10.1016\/j.crad.2023.06.003.","journal-title":"Clin Radiol"},{"key":"2148_CR29","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s00259-022-05783-z","volume":"49","author":"L Monaco","year":"2022","unstructured":"Monaco L, De Bernardi E, Bono F, Cortinovis D, Crivellaro C, Elisei F, et al. The \u201cdigital biopsy\u201d in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2022;49:3401\u201311. https:\/\/doi.org\/10.1007\/s00259-022-05783-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2148_CR30","doi-asserted-by":"publisher","first-page":"5875","DOI":"10.21873\/anticanres.16096","volume":"42","author":"CH Lim","year":"2022","unstructured":"Lim CH, Koh YW, Hyun SH, Lee SJ. A machine learning approach using PET\/CT-based radiomics for prediction of PD-L1 expression in non-small cell lung cancer. Anticancer Res. 2022;42:5875\u201384. https:\/\/doi.org\/10.21873\/anticanres.16096.","journal-title":"Anticancer Res"},{"key":"2148_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.789014","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Ge S, Sang S, Hu C, Deng S. Evaluation of PD-L1 expression level in patients with non-small cell lung cancer by 18F-FDG PET\/CT radiomics and clinicopathological characteristics. Front Oncol. 2021;11:789014. https:\/\/doi.org\/10.3389\/fonc.2021.789014.","journal-title":"Front Oncol"},{"key":"2148_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.acra.2019.04.016","volume":"27","author":"M Jiang","year":"2020","unstructured":"Jiang M, Sun D, Guo Y, Guo Y, Xiao J, Wang L, et al. Assessing PD-L1 expression level by radiomic features from PET\/CT in nonsmall cell lung cancer patients: an initial result. Acad Radiol. 2020;27:171\u20139. https:\/\/doi.org\/10.1016\/j.acra.2019.04.016.","journal-title":"Acad Radiol"},{"key":"2148_CR33","doi-asserted-by":"publisher","first-page":"398","DOI":"10.21037\/tlcr-23-144","volume":"13","author":"Y Bai","year":"2024","unstructured":"Bai Y, Yang W, K\u00e4smann L, Sorich MJ, Tao H, Hu Y. Immunotherapy for advanced non-small cell lung cancer with negative programmed death-ligand 1 expression: a literature review. Transl Lung Cancer Res. 2024;13:398\u2013422. https:\/\/doi.org\/10.21037\/tlcr-23-144.","journal-title":"Transl Lung Cancer Res"},{"key":"2148_CR34","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jtho.2016.04.014","volume":"11","author":"H Yu","year":"2016","unstructured":"Yu H, Boyle TA, Zhou C, Rimm DL, Hirsch FR. PD-L1 expression in lung cancer. J Thorac Oncol. 2016;11:964\u201375. https:\/\/doi.org\/10.1016\/j.jtho.2016.04.014.","journal-title":"J Thorac Oncol"},{"key":"2148_CR35","doi-asserted-by":"publisher","first-page":"19738","DOI":"10.18632\/oncotarget.7582","volume":"7","author":"F Passiglia","year":"2016","unstructured":"Passiglia F, Bronte G, Bazan V, Natoli C, Rizzo S, Galvano A, et al. PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis. Oncotarget. 2016;7:19738\u201347. https:\/\/doi.org\/10.18632\/oncotarget.7582.","journal-title":"Oncotarget"},{"key":"2148_CR36","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.3390\/ijms22126288","volume":"22","author":"E Dantoing","year":"2021","unstructured":"Dantoing E, Piton N, Sala\u00fcn M, Thiberville L, Guisier F. Anti-PD1\/PD-L1 immunotherapy for non-small cell lung cancer with actionable oncogenic driver mutations. Int J Mol Sci. 2021;22:6288. https:\/\/doi.org\/10.3390\/ijms22126288.","journal-title":"Int J Mol Sci"},{"key":"2148_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.lungcan.2021.07.012","volume":"159","author":"BM Koomen","year":"2021","unstructured":"Koomen BM, Voorham QJM, Epskamp-Kuijpers CCHJ, Van Dooijeweert C, Van Lindert ASR, Deckers IAG, et al. Considerable interlaboratory variation in PD-L1 positivity in a nationwide cohort of non-small cell lung cancer patients. Lung Cancer. 2021;159:117\u201326. https:\/\/doi.org\/10.1016\/j.lungcan.2021.07.012.","journal-title":"Lung Cancer"},{"key":"2148_CR38","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00262-020-02520-z","volume":"69","author":"J-I Rodriguez-Barbosa","year":"2020","unstructured":"Rodriguez-Barbosa J-I, Azuma M, Zelinskyy G, Perez-Simon J-A, Del Rio M-L. Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model. Cancer Immunol Immunother. 2020;69:1001\u201314. https:\/\/doi.org\/10.1007\/s00262-020-02520-z.","journal-title":"Cancer Immunol Immunother"},{"key":"2148_CR39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41416-023-02297-9","volume":"129","author":"J Li","year":"2023","unstructured":"Li J, Chen R, Chen Y, Xia Q, Zhou X, Xia Q, et al. Relationship between the expression of PD-L1 and 18F-FDG uptake in pancreatic ductal adenocarcinoma. Br J Cancer. 2023;129:541\u201350. https:\/\/doi.org\/10.1038\/s41416-023-02297-9.","journal-title":"Br J Cancer"},{"key":"2148_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2025.05.024","author":"M Salimi","year":"2025","unstructured":"Salimi M, Vadipour P, Khosravi A, Salimi B, Mabani M, Rostami P, et al. CT-based radiomics for predicting PD-L1 expression in non-small cell lung cancer: a systematic review and meta-analysis. Acad Radiol. 2025. https:\/\/doi.org\/10.1016\/j.acra.2025.05.024.","journal-title":"Acad Radiol"},{"key":"2148_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12957-025-03847-6","volume":"23","author":"T Zheng","year":"2025","unstructured":"Zheng T, Li X, Zhou L, Jin J. Predictive value of machine learning for PD-L1 expression in NSCLC: a systematic review and meta-analysis. World J Surg Oncol. 2025;23:199. https:\/\/doi.org\/10.1186\/s12957-025-03847-6.","journal-title":"World J Surg Oncol"},{"key":"2148_CR42","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1080\/0284186x.2018.1445283","volume":"57","author":"M Pavic","year":"2018","unstructured":"Pavic M, Bogowicz M, W\u00fcrms X, Glatz S, Finazzi T, Riesterer O, et al. Influence of inter-observer delineation variability on radiomics stability in different tumor sites. Acta Oncol. 2018;57:1070\u20134. https:\/\/doi.org\/10.1080\/0284186x.2018.1445283.","journal-title":"Acta Oncol"},{"key":"2148_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-025-04892-1","author":"M Salimi","year":"2025","unstructured":"Salimi M, Vadipour P, Houshi S, Yazdanpanah F, Seifi S. MRI-based radiomics for prediction of biochemical recurrence in prostate cancer: a systematic review and meta-analysis. Abdom Radiol. 2025. https:\/\/doi.org\/10.1007\/s00261-025-04892-1.","journal-title":"Abdom Radiol"},{"key":"2148_CR44","doi-asserted-by":"publisher","first-page":"e008592","DOI":"10.1136\/jitc-2023-008592","volume":"12","author":"N John","year":"2024","unstructured":"John N, Schlintl V, Sassmann T, Lindenmann J, Fediuk M, Wurm R, et al. Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC. J Immunother Cancer. 2024;12:e008592. https:\/\/doi.org\/10.1136\/jitc-2023-008592.","journal-title":"J Immunother Cancer"},{"key":"2148_CR45","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj2023078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons, Dhiman P, Riley RD, Beam AL, Calster V, et al. TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378. https:\/\/doi.org\/10.1136\/bmj2023078378.","journal-title":"BMJ"},{"issue":"4","key":"2148_CR46","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.240300","volume":"6","author":"AS Tejani","year":"2024","unstructured":"Tejani AS, Klontzas ME, Gatti AA, Mongan JT, Moy L, Park SH. <article-title update=\"added\">Checklist for Artificial Intelligence in Medical Imaging (CLAIM): 2024 update. Radiology: Artificial Intelligence. 2024;6(4):e240300. https:\/\/doi.org\/10.1148\/ryai.240300.","journal-title":"Radiology: Artificial Intelligence"},{"key":"2148_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s10140-025-02336-3","author":"M Salimi","year":"2025","unstructured":"Salimi M, Vadipour P, Bahadori AR, Houshi S, Mirshamsi A, Fatemian H. Predicting hemorrhagic transformation in acute ischemic stroke: a systematic review, meta-analysis, and methodological quality assessment of CT\/MRI-based deep learning and radiomics models. Emerg Radiol. 2025. https:\/\/doi.org\/10.1007\/s10140-025-02336-3.","journal-title":"Emerg Radiol"},{"key":"2148_CR48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","volume":"14","author":"CL Ramspek","year":"2020","unstructured":"Ramspek CL, Jager KJ, Dekker FW, Zoccali C, van Diepen M. <article-title update=\"added\">External validation of prognostic models: what,\u00a0why, how, when and where? Clin Kidney J. 2020;14:49\u201358. https:\/\/doi.org\/10.1093\/ckj\/sfaa188.","journal-title":"Clin Kidney J"},{"key":"2148_CR49","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.spinee.2020.02.016","volume":"20","author":"VE Staartjes","year":"2020","unstructured":"Staartjes VE, Kernbach JM. Significance of external validation in clinical machine learning: let loose too early? Spine J. 2020;20:1159\u201360. https:\/\/doi.org\/10.1016\/j.spinee.2020.02.016.","journal-title":"Spine J"},{"key":"2148_CR50","doi-asserted-by":"publisher","first-page":"34015","DOI":"10.1109\/ACCESS.2023.3262729","volume":"11","author":"X Xia","year":"2023","unstructured":"Xia X, Zhang R. A novel lung nodule accurate segmentation of PET-CT images based on convolutional neural network and graph model. IEEE Access. 2023;11:34015\u201331. https:\/\/doi.org\/10.1109\/ACCESS.2023.3262729.","journal-title":"IEEE Access"},{"key":"2148_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108827","volume":"179","author":"A Stefano","year":"2024","unstructured":"Stefano A. Challenges and limitations in applying radiomics to PET imaging: possible opportunities and avenues for research. Comput Biol Med. 2024;179:108827. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108827.","journal-title":"Comput Biol Med"},{"key":"2148_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12149-024-01923-7","volume":"38","author":"SA Hosseini","year":"2024","unstructured":"Hosseini SA, Shiri I, Ghaffarian P, Hajianfar G, Avval AH, Seyfi M, et al. The effect of harmonization on the variability of PET radiomic features extracted using various segmentation methods. Ann Nucl Med. 2024;38:493\u2013507. https:\/\/doi.org\/10.1007\/s12149-024-01923-7.","journal-title":"Ann Nucl Med"},{"key":"2148_CR53","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s13246-024-01475-0","volume":"47","author":"SA Hosseini","year":"2024","unstructured":"Hosseini SA, Hajianfar G, Ghaffarian P, Seyfi M, Hosseini E, Aval AH, et al. Pet radiomics-based lymphovascular invasion prediction in lung cancer using multiple segmentation and multi-machine learning algorithms. Phys Eng Sci Med. 2024;47:1613\u201325. https:\/\/doi.org\/10.1007\/s13246-024-01475-0.","journal-title":"Phys Eng Sci Med"},{"key":"2148_CR54","doi-asserted-by":"publisher","first-page":"e05267","DOI":"10.1016\/j.heliyon.2020.e05267","volume":"6","author":"M Tamal","year":"2020","unstructured":"Tamal M. Intensity threshold based solid tumour segmentation method for positron emission tomography (PET) images: a review. Heliyon. 2020;6:e05267. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e05267.","journal-title":"Heliyon"},{"key":"2148_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.compeleceng.2022.108545","volume":"105","author":"Z Chen","year":"2023","unstructured":"Chen Z, Qiu N, Feng H, Dai D. PET-CT image co-segmentation of lung tumor using joint level set model. Comput Electr Eng. 2023;105:108545. https:\/\/doi.org\/10.1016\/j.compeleceng.2022.108545.","journal-title":"Comput Electr Eng"},{"key":"2148_CR56","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13550-020-00639-9","volume":"10","author":"X Wu","year":"2020","unstructured":"Wu X, Huang Y, Zhao Q, Wang L, Song X, Li Y, et al. PD-L1 expression correlation with metabolic parameters of FDG PET\/CT and clinicopathological characteristics in non-small cell lung cancer. EJNMMI Res. 2020;10:51. https:\/\/doi.org\/10.1186\/s13550-020-00639-9.","journal-title":"EJNMMI Res"},{"key":"2148_CR57","first-page":"186","volume":"19","author":"MB Shadmehr","year":"2020","unstructured":"Shadmehr MB, Khosravi A, Abbasi Dezfouli A, Bakhshayesh-Karam M, Jamaati H, Doroudinia A, et al. Clinical significance of quantitative FDG PET\/CT parameters in Non-Small cell lung cancer patients. TANAFFOS (Respiration). 2020;19:186\u201394.","journal-title":"TANAFFOS (Respiration)"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02148-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02148-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02148-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:59:45Z","timestamp":1772024385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02148-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2148"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02148-y","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As this study is a review and does not involve human or animal subjects, ethical approval and Institutional Review Board (IRB) oversight were not required in accordance with institutional guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}